Dermapharm Holding SE (DMPHF)
47.69
0.00 (0.00%)
USD |
OTCM |
Oct 06, 16:00
Dermapharm Total Liabilities (Quarterly) : 1.954B for June 30, 2026
Total Liabilities (Quarterly) Chart
Historical Total Liabilities (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 1.954B |
| March 31, 2026 | 1.771B |
| December 31, 2025 | 1.765B |
| September 30, 2025 | 1.728B |
| June 30, 2025 | 1.796B |
| March 31, 2025 | 1.587B |
| December 31, 2024 | 1.533B |
| September 30, 2024 | 1.712B |
| June 30, 2024 | 1.769B |
| March 31, 2024 | 1.713B |
| December 31, 2023 | 1.797B |
| September 30, 2023 | 1.709B |
| June 30, 2023 | 1.737B |
| March 31, 2023 | 1.724B |
| December 31, 2022 | 929.72M |
| September 30, 2022 | 926.63M |
| June 30, 2022 | 1.005B |
| March 31, 2022 | 1.029B |
| Date | Value |
|---|---|
| December 31, 2021 | 1.021B |
| September 30, 2021 | 1.060B |
| June 30, 2021 | 1.083B |
| March 31, 2021 | 1.076B |
| December 31, 2020 | 1.089B |
| September 30, 2020 | 1.076B |
| June 30, 2020 | 1.034B |
| March 31, 2020 | 852.28M |
| December 31, 2019 | 842.22M |
| September 30, 2019 | 817.99M |
| June 30, 2019 | 803.56M |
| March 31, 2019 | 770.09M |
| December 31, 2018 | 501.74M |
| September 30, 2018 | 520.05M |
| June 30, 2018 | 550.00M |
| March 31, 2018 | 589.51M |
| December 31, 2017 | 398.18M |
| September 30, 2017 | 424.60M |
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Liabilities (Quarterly) Benchmarks
| AstraZeneca PLC | 66.63B |
| ANI Pharmaceuticals, Inc. | 896.90M |
| Corcept Therapeutics, Inc. | 182.93M |
| Veru, Inc. | 8.651M |
| Avadel Pharmaceuticals Plc | 101.22M |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 2.564B |
| Shareholders Equity (Quarterly) | 613.63M |
| Debt to Equity Ratio | 2.178 |
| Current Ratio | 1.712 |
| Net Debt Paydown Yield | -1.99% |